Journal article Open Access

Adverse effects of anticancer agents that target the VEGF pathway

Chen, Helen X.; Cleck, Jessica N.

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="">
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u"></subfield>
    <subfield code="a">Creative Commons Zero v1.0 Universal</subfield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2009-07-07</subfield>
  <controlfield tag="005">20200120173229.0</controlfield>
  <controlfield tag="001">1233504</controlfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="o"></subfield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Antiangiogenic agents that target the VEGF pathway have become an important part of standard therapy in multiple cancer indications. Although most adverse effects of VEGF inhibitors are modest and manageable, some are associated with serious and life-threatening consequences. This Review examines the toxicity profiles of anti-VEGF monoclonal antibodies and small-molecule inhibitors and considers the potential mechanisms of the adverse effects, risk factors, and the implications for patient management.</subfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Cleck, Jessica N.</subfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">431955</subfield>
    <subfield code="z">md5:a7d0ea826813257208ff06503d1c294e</subfield>
    <subfield code="u"></subfield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Chen, Helen X.</subfield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1038/nrclinonc.2009.94</subfield>
    <subfield code="2">doi</subfield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Adverse effects of anticancer agents that target the VEGF pathway</subfield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2"></subfield>
Views 688
Downloads 539
Data volume 232.8 MB
Unique views 661
Unique downloads 500


Cite as